HK1067642A1 - Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs - Google Patents

Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs

Info

Publication number
HK1067642A1
HK1067642A1 HK05100756A HK05100756A HK1067642A1 HK 1067642 A1 HK1067642 A1 HK 1067642A1 HK 05100756 A HK05100756 A HK 05100756A HK 05100756 A HK05100756 A HK 05100756A HK 1067642 A1 HK1067642 A1 HK 1067642A1
Authority
HK
Hong Kong
Prior art keywords
glucocerebrosidase
analogs
beta
novel
activators
Prior art date
Application number
HK05100756A
Other languages
English (en)
Inventor
Rie Uematsu
Fumio Nakajima
Masahiro Yoshida
Kyoko Fukunaga
Mariko Hara
Shintaro Inoue
Shinichiro Nishimura
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Publication of HK1067642A1 publication Critical patent/HK1067642A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
HK05100756A 2001-06-28 2005-01-28 Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs HK1067642A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001196016A JP4070966B2 (ja) 2001-06-28 2001-06-28 新規ガラクトシルセラミド類縁体及び用途
PCT/JP2002/006532 WO2003002584A1 (fr) 2001-06-28 2002-06-27 Nouveaux analogues de galactosylceramide et activateurs de $g(b)-glucocerebrosidase, preparations externes pour la peau et procede d'activation de $g(b)-glucocerebrosidase au moyen d'analogues

Publications (1)

Publication Number Publication Date
HK1067642A1 true HK1067642A1 (en) 2005-04-15

Family

ID=19033898

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05100756A HK1067642A1 (en) 2001-06-28 2005-01-28 Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs

Country Status (9)

Country Link
US (2) US7183261B2 (fr)
EP (1) EP1408045B1 (fr)
JP (1) JP4070966B2 (fr)
KR (1) KR100739250B1 (fr)
CN (1) CN1247605C (fr)
DE (1) DE60232449D1 (fr)
HK (1) HK1067642A1 (fr)
TW (2) TWI322151B (fr)
WO (1) WO2003002584A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101936685B1 (ko) * 2011-11-16 2019-01-11 (주)아모레퍼시픽 글리코실 세라마이드 유사 화합물, 이의 제조방법 및 이를 함유하는 화장료 조성물
JP5918168B2 (ja) * 2012-04-27 2016-05-18 富士フイルム株式会社 β−グルコセレブロシダーゼ活性増強剤
US20150224129A1 (en) 2012-10-03 2015-08-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
KR101589633B1 (ko) * 2014-09-18 2016-02-01 한국과학기술연구원 당세라마이드 유도체 및 이의 제조방법
CA2966581A1 (fr) 2014-11-06 2016-05-12 Lysosomal Therapeutics Inc. Pyrrolo[1,2-a]pyrimidines substituees et leur utilisation dans le traitement de troubles medicaux
EP3215510B1 (fr) 2014-11-06 2023-06-07 Bial-R&D Investments, S.A. Imidazo[1,5-a]pyrimidines substituées et leur utilisation dans le traitement de troubles médicaux
MX2017005940A (es) 2014-11-06 2018-01-11 Lysosomal Therapeutics Inc Pyrazolo [1, 5-a] pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos.
WO2017027848A1 (fr) * 2015-08-12 2017-02-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Peptides glycosylés comportant des résidus de pseudoproline et présentant une demi-vie prolongée et une capacité accrue à traverser la barrière hémato-encéphalique
US10709758B2 (en) 2015-09-03 2020-07-14 The Board Of Regents Of The University Of Oklahoma Peptide inhibitors of clostridium difficile toxin B (TcdB) toxin
EP3440081A4 (fr) 2016-04-06 2019-09-18 Lysosomal Therapeutics Inc. Composés pyrrolo[1,2-a]pyrimidinyl carboxamide et leur utilisation dans le traitement de troubles médicaux
KR20180133461A (ko) 2016-04-06 2018-12-14 리소소말 테라퓨틱스 인크. 피라졸로[1,5-a]피리미디닐 카르복스아미드 화합물 및 의학적 장애의 치료에서의 그의 용도
CA3020305A1 (fr) 2016-04-06 2017-10-12 Lysosomal Therapeutics Inc. Composes imidazo [1,5-a]pyrimidinyl carboxamide et leur utilisation dans le traitement de troubles medicaux
JP7164774B2 (ja) 2016-05-05 2022-11-02 ビアル－アール・アンド・ディ・インベストメンツ・ソシエダーデ・アノニマ 置換イミダゾ［１，２－ｂ］ピリダジン、置換イミダゾ［１，５－ｂ］ピリダジン、関連化合物、および医学的障害の治療におけるその使用
EP3452455A4 (fr) 2016-05-05 2019-11-13 Lysosomal Therapeutics Inc. Imidazo[1,2-a]pyridines substituées, imidazo[1,2-a]pyrazines substituées, composés apparentés et leur utilisation dans le traitement de troubles médicaux
WO2017207040A1 (fr) 2016-06-01 2017-12-07 Vib Vzw Thérapie anticancéreuse utilisant un antagoniste de la leptine et un activateur des cellules inkt
US10933126B2 (en) 2018-05-03 2021-03-02 The Board Of Regents Of The University Of Oklahoma Clostridium difficile immunogenic compositions and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07110872B2 (ja) * 1990-09-25 1995-11-29 株式会社ディ・ディ・エス研究所 酸性糖脂質及び微粒子キャリヤー
JP2774417B2 (ja) * 1991-08-07 1998-07-09 株式会社ディ・ディ・エス研究所 ペプチド骨格を有する分枝鎖型糖複合体及び微粒子キャリヤー
IT1271624B (it) * 1994-03-21 1997-06-04 Lifegroup Spa Derivati glucosidici di n-acil alchilamine capaci di esercitare effetto o neuroprotettivo utilizzabili nelle patologie acute e croniche del sistema nervoso centrale correlate ad eccitotossicita'
JP2896321B2 (ja) * 1994-10-27 1999-05-31 鐘紡株式会社 β−グルコセレブロシダーゼの活性化方法

Also Published As

Publication number Publication date
KR20040048381A (ko) 2004-06-09
JP4070966B2 (ja) 2008-04-02
DE60232449D1 (de) 2009-07-09
TWI322151B (fr) 2010-03-21
EP1408045B1 (fr) 2009-05-27
TW201002734A (en) 2010-01-16
CN1522263A (zh) 2004-08-18
EP1408045A1 (fr) 2004-04-14
KR100739250B1 (ko) 2007-07-12
US20070111951A1 (en) 2007-05-17
CN1247605C (zh) 2006-03-29
EP1408045A4 (fr) 2005-12-28
US7183261B2 (en) 2007-02-27
JP2003012684A (ja) 2003-01-15
US20040242499A1 (en) 2004-12-02
WO2003002584A1 (fr) 2003-01-09

Similar Documents

Publication Publication Date Title
HK1067642A1 (en) Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs
EP1570839A4 (fr) Composition pour une preparation destinee a un usage externe sur la peau, et methode d'utilisation s'y rapportant
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
EP1374935A4 (fr) Aiguille de seringue medicale et procede de production de cette aiguille
IL196301A0 (en) Medicament for the treatment of hapatitis c
GB0112699D0 (en) Process for the preparation of prostglandins and analogues thereof
EP1240891A3 (fr) Composition pour la coloration des cheveux humains
AU2003224458A1 (en) Skin whitening external preparation
IL159067A0 (en) METHODS FOR PREPARATION AND USE OF 1alpha,24 (S) -DIHYDROXYVITAMIN D2
EP1582195A4 (fr) Agent de blanchiment, preparation de soin cutane a usage externe et produit cosmetique
EP1261623A4 (fr) Nouveaux derives de retinol, procede de preparation et d'utilisation de ceux-ci
EP1370241A4 (fr) Emulsion multi-lamellaire permettant la stabilisation d'ingredients dermatologiquement actifs, et preparations de base a usage externe pour dermatoses generales
EP1505139A4 (fr) Agent epaississant, preparation cosmetique en contenant, et son procede de production
EP1355621A4 (fr) Composition blanchissante contenant de l'arbutine et de la glucosidase en tant qu'ingredients actifs
AU2003272968A8 (en) Tyrosinase activity controlling agents, process for producing the same and external preparations containing the same
GB2360453B (en) Treatment of skin conditions
EP1260211A4 (fr) Preparations dermatologiques pour usage externe
GB0101146D0 (en) Treatment of skin conditions
AU2509801A (en) Method for the cosmetic treatment of human skin
IL158587A0 (en) Novel 5-thio-ss-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and the therapeutic use thereof
AU2003201853A1 (en) Skin preparations for external use
EP1372594A4 (fr) Derives d'acide kojique stables a l'eau et leur procede de preparation et composition pour cosmetiques decolorants renfermant ces derives
AU2003252357A8 (en) Sphingosinoids and external preparations for skin containing the same
AU2001271048A1 (en) Method for massaging human skin
EP1488776A4 (fr) Derives de phenylacetonitrile, tonique capillaire et preparations externes pour la peau contenant ces derives

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20220626